Proyectos Europeos

Para más información, contactar con el equipo de getión de proyectos Internacionales en oficina.idi(ELIMINAR)@irycis.org 

MISTAR

JPI

Microbiota Intervention Strategies Limiting Selection and Transmission of Antibiotic Resistance burden in the One Health domain

Dr. María Teresa Coque González

Más información

SO-NUTS

JU

Preventing obesity, sarcopenia, and Sarcopenic Obesity in retirement - digital personalized interventions for healthy NUTrition and physical activity for Seniors.

Dr. Alfonso J. Cruz Jentoft

Más información

NANO4GLIO

JU

Nanomedicine for glioblastoma therapy

Dr. Mª Ángeles Vaz Salgado

Más información

ST131TS

JPI

Escherichia coli ST131: a model for high-risk transmission dynamics of antimicrobial resistance.

Dr. Fernando Baquero

MaNuEL

JPI

Malnutrition in the Elderly Knowledge Hub

Dr. Alfonso José Cruz Jentoft

Más información

European upconversion network.

COST

The European upconversion network - from the design of photon-upconverting nanomaterials to biomedical applications (CM1403).

Dr. Daniel Jaque

Más información

Nano2Clinic

COST

Cancer Nanomedicine – from the bench to the bedside (CA17140)  

Dr. Daniel Jaque

Más información

REPLAY (MSCA-IF)

MSCA / ERC

Analysing the role of history, chance and selection on the evolution of plasmid-mediated antibiotic resistance (895671).

Dr. Alfonso Santos

Más información

RETENTION

H2020

heaRt failurE paTient managEment and iNTerventIOns usiNg continuous patient monitoring outside hospitals and real world data (965343)

Dr. José Luis Zamorano

Más información

RESILIENCE

H2020

Remote Ischemic Conditioning in Lymphoma Patients Receiving Anthracyclines (945118).

Dr. Javier López Jiménez

Más información

VISION

H2020

Strategies to strengthen scientific excellence and innoVation capacIty for early diagnoSIs of gastrOintestinal caNcers (857381)

Dr. Alfredo Carrato

Más información

MICROCARE

FP7

A multicenter, randomized, placebo-controlled, parallel-arm clinical trial to evaluate the efficacy of DAV132 in preventing Clostridioides difficile infection in patients with newly diagnosed Acute Myeloid Leukemia or high-risk Myelodysplastic Syndrome treated with intensive chemotherapy.

Dr. Francisco Javier Cobo

Más información